Advertisement

Lyzed gonococci in the treatment of gonococcus cervicovaginitis

Preliminary report
  • Maurice L. Blatt
    Affiliations
    Department of Genito-Urinary Surgery, University of Illinois, Chicago, Ill. USA

    Department of Pediatrics, University of Illinois, Chicago, Ill. USA

    Cook County Children's Hospital, Chicago, Ill. USA
    Search for articles by this author
  • Russell D. Herrold
    Affiliations
    Department of Genito-Urinary Surgery, University of Illinois, Chicago, Ill. USA

    Department of Pediatrics, University of Illinois, Chicago, Ill. USA

    Cook County Children's Hospital, Chicago, Ill. USA
    Search for articles by this author
  • Samuel J. Hoffman
    Affiliations
    Department of Genito-Urinary Surgery, University of Illinois, Chicago, Ill. USA

    Department of Pediatrics, University of Illinois, Chicago, Ill. USA

    Cook County Children's Hospital, Chicago, Ill. USA
    Search for articles by this author
  • Maurice Schneider
    Affiliations
    Department of Genito-Urinary Surgery, University of Illinois, Chicago, Ill. USA

    Department of Pediatrics, University of Illinois, Chicago, Ill. USA

    Cook County Children's Hospital, Chicago, Ill. USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Summary

      Bacteriophage lyzed gonococcus antigen has produced results through preliminary observations that indicate it to be an efficient agent in treatment of gonococcus cervicovaginitis in children. This product does not produce disagreeable local or general reactions. Nine of eleven patients treated have remained clinically and bacteriologically cured for an average period of five months while a control group not so treated had recurrences in every instance.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Biologic Therapy of Gonococcus Vulvovaginitis, Veneral Disease Information. Vol. XI. U. S. Treasury Department, Sept. 20, 1930